Rob Kossmann, MD, FACP, FASN
Chief Medical Officer
Fresenius Medical Care North America

Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Chief Medical Officer
Fresenius Medical Care North America
As Executive Vice President, Fresenius Medical Care North America, and our Chief Medical Officer, Dr. Rob Kossmann leads clinical care for our company throughout North America. From 2014 to 2019, he served as senior vice president and chief medical officer for Fresenius Medical Care’s Renal Therapies Group, the company’s medical equipment and renal pharmaceuticals division, and he continues to serve as the head of renal therapies for our Global Medical Office.
Rob is a leader in the field of nephrology, and formerly served as president of the Renal Physicians Association (RPA). He is also a founding member of the RPA's Nephrology Coverage Advocacy Program, and previously served as a nephrology advisor to the American Medical Association's Relative Value Scale Update Committee.
A practicing nephrologist for more than two decades, Rob trained at the University of Washington and earned a doctor of medicine degree from Case Western Reserve University.
© 2006-2023 Fresenius Medical Care. All Rights Reserved.